Enterome vs Signadori Bio

Enterome vs Signadori Bio, compared side by side on 17 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Enterome is on 60/100 and Signadori Bio on 45/100.

Enterome logo
EnteromeClinical-stage biopharmaceutical company developing microbiome-derived immunotherapies for cancer and immune diseases.
Try Enterome
Signadori Bio logo
Signadori BioDeveloping a next-generation, off-the-shelf, in vivo engineered monocyte immunotherapy platform for solid tumors.
Try Signadori Bio

Where each one leads

Enterome

  • our overall score: 60/100 against 45/100
  • domain rating: 46/100 against 6/100
  • funding raised: $124M against $12.2M

Signadori Bio

  • agent readiness: 40/100 against 21/100

At a glance

MeasureEnteromeSignadori Bio
What it isClinical-stage biopharmaceutical company developing microbiome-derived immunotherapies for cancer and immune diseases.Developing a next-generation, off-the-shelf, in vivo engineered monocyte immunotherapy platform for solid tumors.
CategoryBiotechnology, Drug Discovery, Oncology, ImmunotherapyBiotechnology, Pharmaceuticals, Oncology, Immunotherapy
Sells toBusiness modelB2BB2B
OfferingSoftware | hardware | services | marketplace | platformPlatform
Founded20122025
HeadquartersParis, FranceParis, France
StatusActiveInactive

Size, funding and growth

MeasureEnteromeSignadori Bio
Employees33Not published
Total funding$124M$12.2M
Latest roundLater Stage VCSeed Extension
LinkedIn followers16,846Not published

StartupHub scores

Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.

MeasureEnteromeSignadori Bio
StartupHub scoreOur 0-100 rating60/10045/100
Traction55/10035/100
Team70/10070/100
Search visibility34/10016/100
Quality68/10050/100
Agent readinessHow well an AI agent can read and act on the siteF (21/100)D (40/100)
Domain ratingLink authority, 0-10046/1006/100

Technology

Detected on each public site, so it reflects the marketing stack as well as the product.

MeasureEnteromeSignadori Bio
HostingSelf ManagedNot detected
CDNNot detectedCloudflare
CMSWordPressLovable
FrameworksBootstrapNot detected
AnalyticsGoogle Analytics 4, SegmentNot detected

Enterome vs Signadori Bio: common questions

Which is better, Enterome or Signadori Bio?

On our 0-100 score Enterome rates higher (60/100 against 45/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 17 data points above: read the rows that match what you are buying for.

How do Enterome and Signadori Bio compare on the numbers?

Enterome leads on our overall score (60/100 against 45/100), domain rating (46/100 against 6/100), funding raised ($124M against $12.2M). Signadori Bio leads on agent readiness (40/100 against 21/100).

Read the full Enterome review and pricing or the Signadori Bio review and pricing. You can also browse other Enterome alternatives we track.